A government cap on trade margins has cut the maximum retail prices (MRPs) of nearly three-fourths of listed cancer drug brands, with more than 200 formulations…
Trending
- Samsung 75-inch M80H TV hits its lowest price yet on Amazon
- Cancer drug price cap: Despite steepest cuts on generics, biosimilars, most patented, single-brand drugs keep their prices
- WATCH: In conversation with Mishal Husain at Cadogan Hall
- Audubon Mural Project in South Beloit, IL
- Rory McIlroy to play in tournaments despite players skipping amid security concerns
- Opera WebAI Runs Local AI Models in Your Browser
- MDR uncertainty, choppy markets cloud ₹33,600-crore fintech IPO pipeline
- Alastair Campbell’s diary: The truth that Northern Ireland has never confronted
